What is America's success in the coronavirus vaccine?

The first Covid-19 vaccine tested in the US has provided the benefits of immunity to the people as scientists had expected.Now the important trial of this vaccine has to be done. America's top expert Dr. Anthony Fauchi told the news agency Associated Press, "No matter how much you cut it, it is good news."

This news has also been published by the New York Times. Information related to its trial is posted on clinicaltrials.gov. A study is going on about this and will continue until October 2022.Dr. Fauchi's colleagues at the National Institutes of Health and Moderna Inc. have developed this vaccine.

Now the most important phase of this vaccine will start from 27 July. It will be tested on thirty thousand people and it will be known whether this vaccine can save the human body from Covid-19.On Tuesday, researchers released the results of tests conducted on 45 people. They were waiting impatiently.

Neutralizing antibodies have developed in the body of these volunteers. These antibodies are important to prevent infection.

The research team wrote in the New England Journal of Medicine that the vaccine's volunteer has found as many antibodies in the blood as those found in the body of patients recovering from Covid-19.

Dr. Lisa Jackson, of Seattle's Saffron Permanent Washington Research Institute, who led the research, says it is a necessary building block to move forward in testing and find out if a vaccine can prevent infection.

There is no guarantee when the final results will be received, but the government hopes that the trial will be completed by the end of the year. To develop the vaccine, it is a record speed.Two vaccines will be given between this vaccine, which will have a gap of one month. This vaccine has no serious side effects.

But more than half of the people involved in the research have reported a flu-like reaction. This is not uncommon with other vaccines.

Headaches, feeling cold, fever, or having pain in place of vaccines are common after vaccination. These reactions were more severe among the three participants who were given higher doses. Now that quantity is not being tested.

Some reactions are similar to symptoms of coronavirus infection, but they are temporary. They last for a day and begin appearing immediately after being vaccinated.

Researcher at the Vanderbilt University Medical Center, Dr. William Schaffner, says that this is a small price for protection from an epidemic like Corona. Dr. Schaffner is not involved with this research.

He has described the initial results of the vaccine as a good step. They hope that the final trial of the drug will show whether it is safe and effective. These results will be available by the beginning of next year.Schaffner says it will be great, provided everything is on its own. After the initial results came out on Tuesday, the shares of Moderna Inc rose to fifteen percent in the US stock market.

Shares of the company based in Cambridge, Massachusetts, USA have increased four times this year. Only the youth were involved in the research results released on Tuesday. The elderly are also being included in the upcoming test. The elderly most affected by the Covid-19 epidemic has occurred.

According to the news agency Associated Press, the results of the research are not yet public and the regulator is analyzing them.

Fauchi says that the elderly will also be included in the final round of trials. Apart from this, people suffering from serious diseases will also be tested. The most impact of this virus is only on those who were suffering from some diseases before.

Not only this, people of Black and Latin origin have also been affected more by this infection in the US. Around two dozen vaccines worldwide are in the final stages of their trials. The vaccines of Oxford University in China and Britain are also coming to the final stage of trials soon.

The research of this vaccine, which is going to be done on 30 thousand people, will be the biggest research of the possible vaccine of Corona so far.

However, this vaccine is not the only vaccine that will be tested on this large scale. The government is also preparing to do a big research on the Oxford vaccine and the Johnson & Johnson vaccine. Apart from this, there will also be a large-scale study of the vaccine of Fizer Company.

People can register themselves as volunteers for this research. Dr. Fauchi says that people think one vaccine will win in this race but I am encouraging everyone. They say we need many vaccines, we need vaccines for the whole world, not one country. for.

Governments around the world are investing in vaccines, so that vaccination can be done on time if a vaccine proves effective.